Eli Lilly said on Tuesday that patients in ​a late-stage trial who had been taking an injectable GLP-1 medication for over a ...

Eli Lilly and Company today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound ...

GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...

Until recently, the most effective new obesity medications, including semaglutide (Wegovy) and tirzepatide (Zepbound), were ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDevdatt Kurdikar - President, CEO ...

We reviewed popular telehealth and pharmacy options for finding Zepbound online. Here are the top providers for safe access and ongoing support.

Detailed price information for Surenano Science Ltd (SURE-CN) from The Globe and Mail including charting and trades.

GoodRx reports that Foundayo, a new oral weight-loss pill, is FDA-approved for obesity treatment, offering an alternative to ...

In recent years, weight-loss drugs have become a common addition to diet and exercise routines. The rise of GLP-1 medications ...

Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity ...